Application du natalizumab dans le traitement de la sclérose en plaque (expérience de la wilaya de Mila) : étude réalisée au niveau de l’établissement public hospitalier « frères Tobal » et « BBoumediene chelghoum laïd » (wilaya de Mila)

Abstract

Natalizumab is a monoclonal antibody used as a disease-modifying therapy for very active forms of multiple sclerosis. Our study on its therapeutic effects, adverse effects, and impact on patients ‘daily lives shows that this molecule is effective and well-tolerated, offering a significant reduction in relapses, minimal side effects and an improvement in patients’ quality of life